Molecular neuroanatomy of human monoamine oxidases A and B revealed by quantitative enzyme radioautography and in situ hybridization histochemistry

Neuroscience

Volumn 70, Issue 3, 1996, Pages 755-774

  Saura, J ^d   Bleuel, Z ^a   Ulrich, J ^b   Mendelowitsch, A ^b   Chen, K ^c   Shih, J C ^c   Malherbe, P ^a   Da Prada, M ^e   Richards, J G ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF BARCELONA   (Spain)

^e NONE

Author keywords

catalytic sites; human CNS; localization; MAO A; MAO B; mRNA

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; LAZABEMIDE; N (2 AMINOETHYL) 5 (3 FLUOROPHENYL) 4 THIAZOLECARBOXAMIDE;

ADULT; AGED; ARTICLE; BRAIN REGION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; MONOAMINE METABOLISM; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0030052403     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(96)83013-2     Document Type: Article

References (78)

1. Abell C. W., Stewart R. M., Andrews P. J. and Kwan S.-W. (1994) Molecular and functional properties of the monoamine oxidases. Heterocycles 39, 933-955.
2. Adell A., Carceller A. and Artigas F. (1993) In vivo brain dialysis study of the somatodendritic release of serotonin in the raphe nuclei of the rat. Effects of 8-OH-DPAT. J. Neurochem. 60, 1673-1681.
3. Adolfsson R., Gottfries C. G., Oreland L., Wiberg A. and Winblad B. (1980) Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type. Life Sci. 21, 1029-1034.
4. Arai R., Karasawa N., Geffard M., Nagatsu T. and Nagatsu I. (1994) Immunohistochemical evidence that central serotonin neurons produce dopamine from exogenous L-DOPA in the rat, with reference to the involvement of the aromatic L-amino acid decarboxylase. Brain Res. 667, 295-299.
5. Arai R., Kimura H. and Maeda T. (1986) Topographic atlas of monoamine oxidase-containing neurons in the rat brain studied by an improved histochemical method. Neuroscience 19, 905-925.
6. Azmitia E. C. and Gannon P. J. (1986) The primate serotoninergic system: a review of human and animal studies and a report on Macaca fascicularis. Adv. Neurol. 43, 407-468.
7. Bach A. W. J., Lan N. C., Johnson D. L., Abell C. W., Bembenek M. E., Kwan S. W., Seeburg P. and Shih J. C. (1988) cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties. Proc. natn. Acad. Sci. U.S.A. 85, 4934-4938.
8. Barton A. J. L., Pearson R. C. A., Najlerahim A. and Harrison P. J. (1993) Pre- and postmortem influences on brain RNA. J. Neurochem. 61, 1-11.
9. Bevan Jones A. B., Pare C. M. B., Nicholson W. J., Price K. and Stacey R. S. (1972) Brain amine concentrations after monoamine oxidase inhibitor administration. Br. med. J. 1, 17-19.
10. Boulton A. A. (1976) Identification, distribution, metabolism and function of meta- and para-tyramine, phenethylamine and tryptamine in brain. Adv. biochem. Psychopharmac. 15, 57-67.
11. Cesura A. M. and Pletscher A. (1992) The new generation of monoamine oxidase inhibitors. Prog. Drug Res. 38, 171-297.
12. Chai S. Y., McKinley M. J., Paxinos G. and Mendelsohn F. A. O. (1991) Angiotensin converting enzyme in the monkey (Macaca fascicularis) brain visualized by in vitro autoradiography. Neuroscience 42, 483-495.
13. Chan-Palay V., Höchli M., Jentsch B., Leonard B. and Zetzsche T. (1992) Raphe serotonin neurons in the human brain stem in normal controls and patients with senile dementia of the Alzheimer type and Parkinson's disease: relationship to monoamine oxidase enzyme localization. Dementia 3, 253-269.
14. Chan-Palay V., Höchli M., Savaskan E. and Hungerecker G. (1993) Calbindin D-28k and monoamine oxidase A immunoreactive neurons in the nucleus basal is of Meynert in senile dementia of the Alzheimer type and Parkinson's disease. Dementia 4, 1-15.
15. Cohen G. (1986) Monoamine oxidase, hydrogen peroxide, and Parkinson's disease. Adv. Neurol. 45, 119-125.
16. Da Prada M., Zürcher G., Kettler R., Dingemanse J., Jorga K. and Dubuis R. (1994) Remodelling the kinetics and dynamics of levodopa therapy in Parkinson's disease by inhibiting MAO-B with lazabemide and COMT with tolcapone. In Levodopa - the First 25 Years (eds Poewe W. and Lees A. J.), pp. 99-117. Editiones Roche, Switzerland.
17. De Armond S. J., Fusco M. M. and Dewey M. M. (1989) Structure of the Human Brain, A Photographic Atlas, 3rd edn. Oxford University Press, Oxford.
18. Descarries L., Watkins K. C., Garcia S. and Beaudet A. (1982) The serotonin neurons in nucleus raphe dorsalis of adult rat: a light and electron microscope radioautographic study. J. comp. Neurol. 207, 239-254.
19. Fowler C. J. and Tipton K. F. (1984) On the substrate specificities of the two forms of monoamine oxidase. J. Pharm. Pharmac. 36, 111-115.
20. Fowler C. J., Wiberg A., Oreland L., Marcusson J. and Winblad B. (1980) The effect of age on the activity and molecular properties of human brain MAO. J. neural Transm. 49, 1-20.
21. Fowler J. S., Volkow N. D., Logan J., Schlyer D. J., MacGregor R. R., Wang G. J., Wolf A. P., Pappas N., Alexoff D., Shea C., Gatley S. J., Dorflinger E., Yoo K., Morawsky L. and Fazzini E. (1993) Monoamine oxidase B (MAO B) inhibitor therapy in Parkinson's disease: the degree and reversibility of human brain MAO B inhibition by Ro19-6327. Neurology 43, 1984-1992.
22. Garrick N. A. and Murphy D. L. (1982) Monoamine oxidase A: differences in selectivity towards l-norepinephrine compared to serotonin. Biochem. Pharmac. 24, 4061-4066.
23. Glover V., Elsworth J. D. and Sandler M. (1980) Dopamine oxidation and its inhibition by (-)deprenyl in man. J. Neurotransm. (Suppl.) 16, 163-172.
24. Gottfries C. G., Oreland L., Wiberg A. and Winberg B. (1975) Lowered monoamine oxidase activity in brains from alcoholic suicides. J. Neurochem. 25, 667-673.
25. Haefely W., Burkard W. P., Cesura A. M., Kettler R., Lorez H. P., Martin J. R., Richards J. G., Scherschlicht R. and Da Prada M. (1992) Biochemistry and pharmacology of moclobemide, a prototype RIMA. Psychopharmacology (Berl.) 106, 6-14.
26. Hökfelt T., Martensson R., Björklund A., Kleinau S. and Goldstein M. (1984) Distributional maps of tyrosine-hydroxylase-immunoreactive neurons in the rat brain. In Handbook of Chemical Neuroanatomy, Vol. 2 (eds Björklund A. and Hökfelt T.), pp. 277-379. Elsevier, Amsterdam.
27. Hough L. B. and Domino E. F. (1979) Tele-methylhistamine oxidation by type B monoamine oxidase. J. Pharmac. exp. Ther. 208, 422-128.
28. Huszti Z., Magyar K. and Kalman M. (1990) Contribution of glial cells to histamine inactivation. Agents Actions 30, 237-239.
29. Johnston J. P. (1968) Some observations upon a new inhibitor of monoamine oxidase in brain tissue. Biochem. Pharmac. 17, 1285-1297.
30. 3H]deprenyl. Brain Res. 547, 69-76.
31. Kalaria R. N., Mitchell M. J. and Harik S. I. (1988) Monoamine oxidases of the human brain and liver. Brain 111, 1441-1451.
32. Kitahama K., Arai R., Maeda T. and Jouvet M. (1986) Demonstration of monoamine oxidase type B in serotonergic and type A in noradrenergic neurons in the cat dorsal pontine tegmentum by an improved histochemical technique. Neurosci. Lett. 71, 19-24.
33. Kitahama K., Denney R. M., Maeda T. and Jouvet M. (1991) Distribution of type B monoamine oxidase immunoreactivity in the cat brain with reference to enzyme histochemistry. Neuroscience 44, 185-204.
34. Kitahama K., Kimura H., Maeda T. and Jouvet M. (1987) Distribution of two types of monoamine oxidase-containing neurons in the cat medulla oblongata demonstrated by an improved histochemical method. Neuroscience 20, 991-999.
35. Konradi C., Kornhuber J., Froelich L., Fritze J., Heinsen H., Beckmann H., Schulz E. and Riederer P. (1989) Demonstration of monoamine oxidase -A and -B in the human brainstem by a histochemical technique. Neuroscience 33, 383-100.
36. Konradi C., Svoma E., Jellinger K., Riederer P., Denney P. and Thibault J. (1988) Topographic immunocytochemical mapping of MAO-A, MAO-B and tyrosine hydroxylase in human post-mortem brain stem. Neuroscience 26, 791-802.
37. 3H]PK-11195 binding sites in human epileptic hippocampus. Epilepsia 33, 610-617.
38. Levitt P., Pintar J. E. and Breakfield X. O. (1982) Immunocytochemical demonstration of MAO-B in brain astrocytes and serotonergic neurons. Proc. natn. Acad. Sci. U.S.A. 79, 6385-6389.
39. Luque J. M., Kwan S.-W., Abell C. W., Da Prada M. and Richards J. G. (1995) Cellular expression of mRNAs encoding monoamine oxidase A and B in the rat central nervous system. J. comp. Neurol. (In press).
40. Major L. F., Murphy D. L., Lipper S. and Gordon E. (1979) Effects of clorgyline and pargyline on deaminated metabolites of norepinephrine, dopamine and serotonin in human cerebrospinal fluid. J. Neurochem. 32, 229-231.
41. Martignoni E., Bomo G., Blandini F., Sinforiani E., Merlo P. and Nappi G. (1991) Monoamines and related metabolite levels in the cerebrospinal fluid of patients with dementia of Alzheimer type. Influence of treatment with L-deprenyl. J. neural Transm. [P-D Sect] 3, 15-25.
42. Moll G., Moll R., Riederer P., Gsell W., Heinsen H. and Denney R. M. (1990) Immunofluorescence cytochemistry on thin frozen sections of human substantia nigra for staining of monoamine oxidase A and monoamine oxidase B, a pilot study. J. neural Transm. (Suppl.) 32, 67-77.
43. Moore R. Y. and Card P. (1984) Noradrenaline-containing neurons systems. In Handbook of Chemical Neuroanatomy Vol. 2, part I (eds Bjorklund A, and Hökfelt T.), pp. 123-156. Elsevier, Amsterdam.
44. Nakamura S., Akiguchi I. and Kimura J. (1993) A subpopulation of mouse striatal cholinergic neurons show monoamine oxidase activity. Neurosci. Lett. 161, 141-144.
45. Nakamura S., Akiguchi I. and Kimura J. (1995) Topographic distribution of monoamine oxidase-B-containing neurons in the mouse stnatum. Neurosci. Lett. 184, 29-31.
46. Nakamura S., Kawamata T., Akiguchi I., Kameyama M., Nakamura N. and Kimura H. (1990) Expression of monoamine oxidase B activity in astrocytes of senile plaques. Acta Neuropath. 80, 319-325.
47. Nakamura S., Kawamata T., Yasuhara O., Akiguchi I., Kimura J., Kimura H. and Kimura T. (1991) The histochemical demonstration of monoamine oxidase-containing neurons in the human hypothalamus. Neuroscience 44, 457-463.
48. Nieuwenhuys R., Voogd J. and van Huijzen Ch. (1988) The Human Central Nervous System. A Synopsis and Atlas, 3rd edn. 437 pp. Springer, Berlin.
49. O'Carroll A. M., Bardsley M. E. and Tipton K. F. (1986) The oxidation of adrenaline and noradrenaline by the two forms of monoamine oxidase from human and rat brain. Neurochem. Int. 8, 493-500.
50. O'Carroll A. M., Fowler C. J., Philips J. P., Tobbia I. and Tipton K. F. (1983) The deamination of dopamine by human brain monoamine oxidase. Specificity for the two enzyme forms in seven brain regions. Naunyn-Schmiedeberg's Arch. Pharmac. 322, 198-202.
51. Oreland L. and Gottfries C. G. (1986) Brain and brain monoamine oxidase in aging and in dementia of Alzheimer's type. Prog. Neuro-psychopharmac. Biol. Psychiat. 10, 533-540.
52. Panula P., Airaksinen M. S., Pirvola U. and Kotilainen E. (1990) A histamine-containing system in human brain. Neuroscience 34, 129-132.
53. Panula P., Takagi H., Inagaki N., Yamatodani A., Tohyama M., Wada H. and Kotilainen E. (1993) Histamine-containing nerve fibres innervate human cerebellum. Neurosci. Lett. 161, 53-56.
54. Paxinos G. ed. (1990) The Human Nervous System. Academic Press, San Diego.
55. Paxinos G. and Watson C. eds (1986) The Rat Brain in Stererotaxic Coordinates, 2nd edn. 119 pp. Academic Press, Australia.
56. Powers R. E., O'Connor D. T. and Price D. L. (1989) Noradrenergic systems in human cerebellum. Brain Res. 481, 194-199.
57. Powers R. E., O'Connor D. T. and Price D. L. (1990) Noradrenergic innervation of the human olivary complex. Brain Res. 523, 151-155.
58. Powers R. E., Strubble R. G., Casanova M. F., O'Connor D. T., Kitt C. A. and Price D. L. (1988) Innervation of human hippocampus by noradrenergic systems: normal anatomy and structural abnormalities in aging and in Alzheimer's disease. Neuroscience 25, 401-417.
59. Probst A., Mengod G., Palacios J. M. (1991) Neurotransmitter receptors in human brain diseases. In Current Topics in Pathology, Vol. 83, Cell Receptors, (ed. Seifert G.), pp. 219-270. Springer, Berlin.
60. Reznikoff G., Manaker S., Parsons B., Harker Rhodes C., Winokur A. and Rainbow T. C. (1986) Localization and quantification of beta-adrenergic receptors in human brain. Neurology 36, 1067-1073.
61. Richards J. G., Saura J., Ulrich J. and Da Prada M. (1991) Molecular neuroanatomy of monoamine oxidases. Psychopharmacology 106, 21-23.
62. Riederer P., Konradi C., Schay V., Kienzl E., Birkmayer G., Danielczyk W., Sofic E. and Youdim M. B. H (1986) Localization of MAO-A and MAO-B in human brain: a step in understanding the therapeutic action of 1-deprenyl. Adv. Neurol. 45, 111-118.
63. 3H]Ro19-6327 in vitro: localization and abundance of MAO-A and MAO-B in rat CNS, peripheral organs and human brain. J. Neurosci. 12, 1977-1999.
64. Saura J., Luque J. M., Cesura A. M., Da Prada M., Chan-Palay V., Huber G., Loeffler J. and Richards J. G. (1994) Increased monoamine oxidase B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography. Neuroscience 62, 15-30.
65. Sparks D. L., Woeltz W. M. and Markesbery W. R. (1991) Alterations in brain monoamine oxidase activity in aging, Alzheimer's disease and Pick's disease. Arch. Neurol. 48, 718-721.
66. Strolin Benedetti M. and Dostert P. (1992) Monoamine oxidase: from physiology and pathophysiology to the design and clinical applications of reversible inhibitors. Adv. Drug Res. 23, 65-125.
67. Suzuki O., Katsumata Y. and Oya M. (1979) 1,4-Methylhistamine is a specific substrate for type B monoamine oxidase. Life Sci. 24, 2227-2230.
68. Waldmeier P. C. (1987) Amine oxidases and their endogenous substrates (with special reference to monoamine oxidase and the brain). J. neural. Transm. (Suppl.) 23, 55-72.
69. Waldmeier P. C., Feldtrauer J. J. and Maitre L. (1977) Methylhistamine: evidence for selective deamination by MAO-B in the rat brain in vivo. J. Neurochem. 29, 785-790.
70. Wessel K. (1993) MAO-B inhibitors in neurological disorders with special reference to selegiline. In Inhibitors of Monoamine Oxidase B. Pharmacology and Clinical Use in Neurodegenerative Disorders (ed. Szelenyi I.), pp. 253-275. Birkhäuser, Basel.
71. Westlund K. N., Denney R. M., Kochersperger L. M., Rose R. M. and Abell C. W. (1985) Distinct monoamine oxidase A and B populations in primate brain. Science 230, 181-183.
72. Westlund K. N., Denney R. M., Rose R. M. and Abell C. W. (1988) Localization of distinct monoamine oxidase A and monoamine oxidase B cell populations in human brainstem. Neuroscience 25, 439-456.
73. Westlund K. N., Krakower T. J., Kwan S. W. and Abell C. W. (1993) Intracellular distribution of monoamine oxidase A in selected regions of rat and monkey brain and spinal cord. Brain Res. 612, 221-230.
74. White H. L. and Glassma A. T. (1977) Multiple binding sites of human brain and liver monoamine oxidase: substrate specificites, selective inhibitions, and attempts to separate enzyme forms. J. Neurochem. 29, 987-997.
75. Wong P. T. H., Leo W. L. and Lee T. (1993) A microdialysis study on striatal dopamine, 5-HT and metabolites in conscious rats after various treatments. Evidence for extravesicular release of dopamine. NeuroReport 5, 53-56.
76. Yamatodani A., Inagaki N., Panula P., Itowi N., Watanabe T. and Wada H. (1991) Structure and functions of the histaminergic neurone system. In Handbook of Experimental Pharmacology, Vol. 97, Histamine and Histamine Antagonists (ed. Uvnas B.), pp. 243-283. Springer, Berlin.
77. Young A. B. and Penney J. B. (1988) Clinical applications of receptor autoradiography. In Receptor Localization: Ligand Autoradiography, pp. 177-189. Alan R. Liss, New York.
78. Zetsche T. and Chan-Palay V. (1992) MAO-A and MAO-B immunoreactivity in the hippocampus, temporal cortex and cerebellum of normal controls and of patients with senile dementia of the Alzheimer type. Dementia 3, 270-281.